Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Table of Contents	211
Sticking With It: The Continued Benefits of 2 Years of Peanut Epicutaneous Immunotherapy in Young Children	159
Indoor and Outdoor Fungal Allergens and Impacts on Respiratory Allergic Disease	134
Carboplatin risk stratification after a hypersensitivity reaction: Progress in our understanding of skin testing	128
Managing CPAP Rhinitis	126
Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults	104
Table of Contents	102
Respiratory Diseases Associated With Organic Dust Exposure	95
Once- or Twice-Daily Inhaler Therapy for Optimal Adherence: “No-Brainer” or Shared Decision?	83
Reply to “Correspondence on ‘Neuropsychiatric events related to montelukast and pranlukast in adults with asthma and rhinitis: a 10-year nationwide population-based study’”	81
Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis?	80
Application of passive monitoring of nighttime respiratory symptoms in chronic asthma management	80
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines	73
Macular Amyloidosis in an Atopic Patient After Aeroallergen Immunotherapy	72
Giant Papillary Conjunctivitis Caused by a Fibroepithelial Polyp of the Lower Eyelid	71
Information for Readers	71
Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80	68
March 2023 Practice Notes	68
COVID-19 Treatments: Then and Now	67
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema	66
Managing Atopic Dermatitis in Patients With Skin of Color	63
Practice Notes from the AAAI	63
CME exam: Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	60
CME exam: Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity	59
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	59

Information for Readers	59
Keeping Our Eyes on the Prize: Personalized and Precision Medicine With Biologics for Chronic Rhinosinusitis With Nasal Polyps	58
Development of Food Allergy Data Dictionary: Toward a Food Allergy Data Commons	57
Measuring Cough Severity: Time to Replace VAS With Patient Global Impression Scale?	57
Quality and Safety: Learning from the Past and (Re)Imagining the Future	57
Allergic Rash Mimickers	56
Impact of Chronic Rhinosinusitis on Long-Term Clinical Outcomes in Adults With Asthma	56
Smoking in severe asthma: Unraveling the overlap with COPD	56
Table of Contents	56
Longitudinal Pathways Between Major Depressive Disorder and Asthma Outcomes in Older Adults	55
Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis	54
Reply to “Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time”	53
Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges	52
Hormonal Contraceptives Are Associated With an Increase in Incidence of Asthma in Women	52
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series	51
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?	50
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases	50
Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada	49
Skin Antiseptics for Atopic Dermatitis: Dissecting Facts From Fiction	48
Resolution of hypereosinophilic syndrome following resection of a schwannoma	48
Assessment of Real-World Escalation to Biologics in US Patients With Asthma	48
Effects of Sex and Gender in Immediate β-Lactam Antibiotic Allergy: A Systematic Review and Meta-Analysis	46
Understanding Health Equity in Patient-Reported Outcomes	45
Identification of motivators and barriers impacting successful food introduction or reintroduction after negative oral food challenges	45
Usability of Graphical User Interfaces With Semiautomatic Delabeling Feature to Improve Drug Allergy Documentation	44
Evolving Food Allergy Clinical Trials to Become More Patient-Centered	44
Artificial Intelligence and Machine Learning for Inborn Errors of Immunity: Current State and Future Promise	43
Facilitated Subcutaneous Immunoglobulin 10% Safety Among Pediatric Patients With Primary Immunodeficiency Diseases	43
Effects of Pregnancy-Onset Asthma on Perinatal Outcomes: A Retrospective Cohort Study	43
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis	42
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	42
Lung Effects of Household Air Pollution	42
Combination of Allergen-Specific Immunotherapy With Biologics in Severe Asthma: Counterintuitive or Rational?	42
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma	42
Feeding difficulties in children with food protein–induced enterocolitis syndrome	42
Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma	41
Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis	41
Disparities in Genetic Testing for Inborn Errors of Immunity	41
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives	41
Generational Consequences From Historical Redlining: Longitudinal Impacts on Air Pollution and Asthma Health Outcomes	41
Comparative diagnostic performance of mx4-IgE versus species-specific IgE for identifying allergic bronchopulmonary aspergillosis	40
The Role of Patient Satisfaction Scores in Clinical Care and Physician Wellness	40
Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?	40
Asthma Management in Children	39
Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?	38
Efficacy of Epinephrine Nasal Spray in the Treatment of Urticaria	38
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use	38
Charting the Seas of Drug Allergy	38
Chronic norovirus infection in immunodeficiency: A UK national case series	38
Epinephrine Nasal Spray Improves Allergic Symptoms in Patients Undergoing Oral Food Challenge, Phase 3 Trial	38

A Media Advocacy Toolkit for the Allergist-Immunologist	38
Reply to “Correlation, causation, and confounding: How worried should we be about dementia risk and second-generation antihistamines?”	37
Endoscopic Evaluation of Patients With Food Allergy for Eosinophilic Esophagitis Before Oral Immunotherapy	37
The impact of COVID-19 on a national sample of US adults with food allergy	37
Gene Therapy for Inborn Errors of Immunity	37
Reducing Health Disparities in Asthma: How Can Progress Be Made	36
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders	36
Diagnosis and Management of Asthma During Pregnancy	36
Prevention of IgE-Mediated Food Allergy: Emerging Strategies Through Maternal and Neonatal Interventions	36
Weight Loss Interventions for Adults With Obesity-Related Asthma	36
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps	36
Oral Food Challenges After Treatment With Omalizumab in the Clinical Setting	36
One Allergy, Two Paths: Navigating Penicillin Allergy Evaluation in Pregnant Patients, Direct Challenges Versus Penicillin Skin Testing in Pregnancy	36
Systemic Therapy for Atopic Dermatitis: Choosing Biologics or Janus Kinase Inhibitors for Children and Adults	36
Blue Wheals and Blue Angioedema Induced by Blue Dyes: A Systematic Review	35
Systemic Therapies for Atopic Dermatitis	35
Anti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials	35
Does atopic dermatitis confer a clinically meaningful risk of cardiovascular disease?	35
Burden of Allergic Disease in Racial and Ethnic Structurally Oppressed Communities Within Canada and the United States: A Scoping Review	35
Comorbid Scenarios in Contact Dermatitis: Atopic Dermatitis, Irritant Dermatitis, and Extremes of Age	34
The Environmental Microbiome, Allergic Disease, and Asthma	34
Allergic bronchopulmonary aspergillosis or tropical pulmonary eosinophilia: discriminatory potential of recombinant Aspergillus fumigatus antigens	34
Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	34
Telehealth and Allergy Services in Rural and Regional Locations That Lack Specialty Services	34
Editorial Board	34
Pharmacokinetics and Pharmacodynamics Following Repeat Dosing of neffy (Epinephrine Nasal Spray) Versus Intramuscular Injection During Induced Allergic Rhinitis	34
The added value of reporting likelihood ratios to laboratory test results in allergy and clinical immunology	34
Use of Antibiotics in Infancy and Asthma in Childhood: Confounded or Causal Relationship? A Critical Review of the Literature	33
Preimplantation genetic testing for hereditary angioedema as a potential dominant cost-effective intervention	33
Allergic Lymphangitis after Hymenoptera Sting	33
Clinical and diagnostic features of 33 patients with aquagenic urticaria	33
Sensitization is persistent in most patients with anaphylaxis to a cephalosporin at 10 years	33
Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab	33
Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation	33
Barriers and Enablers of Dietary Reintroduction Following Negative Oral Food Challenge: A Scoping Review	32
Does Adherence to Inhaled Corticosteroids/Long-Acting β2-Agonists Matter in Patients With Severe Asthma Receiving Biologic Therapies?	32
Inpatient Penicillin Allergy Evaluation—Skin Testing Versus Direct Oral Challenge?	32
Hazelnut Oral Immunotherapy Desensitizes Hazelnut But Not Other Tree Nut Allergies (Nut CRACKER Study)	32
A Multidisciplinary Approach to Checkpoint Inhibitor Adverse Reactions	32
Accelerating Food Allergy Research: Need for a Data Commons	31
Improving Detection of Alpha-1 Antitrypsin Deficiency: Role of the Allergist	31
AIR Therapy: Improving Patient and Planetary Health	31
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or Older	31
Table of Contents	31
Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome	30
Cost Control Versus Optimal Patient Care in Hereditary Angioedema	30
Infrared-induced hives	30
CME exam: The Microbiome as a Gateway to Prevention of Allergic Disease Development	30
The Th17/IL-17 Axis and Host Defense Against Fungal Infections	30
Domiciliary assessment of the type 2 inflammatory FeNO type	30
Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility	30
Immediate adverse reactions to horse antithymocyte globulin: A 10-year single-center experience	30
September 2023 Practice Notes	30
December 2023 Practice Notes	30
Remission of indolent systemic mastocytosis in the absence of targeted therapy	30
Clinical Characteristics of Irritant-Induced Occupational Asthma	29
Systemic Inflammation in Asthma: What Are the Risks and Impacts Outside the Airway?	29
Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey	29
Factors Associated With Asthma Biologic Prescribing and Primary Adherence Among Adults in a Large Health System	29
Effect of Weight Loss on Asthma in Obese Adult Patients With Asthma: A Systematic Review and Meta-Analysis	29
Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency	29
Preparing the Allergist/Immunologist for the Next Pandemic	29
Severity Trend of Recurrence in Pediatric Food Protein-Induced Enterocolitis Syndrome	29
Organizing pneumonia in patients on dupilumab therapy for nasal polyposis: A report of three cases	28
Walnut Threshold Dose Distribution and Safe Dose in Allergic Patients (Nut CRACKER Study)	28
Table of Contents	28
Global Real-World Validation of First-Day Urticaria Activity Score (UAS1)	28
Disease Course of Eosinophilic Esophagitis Under Anti-inflammatory Treatment	28
Multiple chemical sensitivity/idiopathic environmental intolerance: A disability-rights, patient-led perspective	28
Frequent Allergic Sensitization to Farmed Edible Insects in Exposed Employees	28
Hypertension risk in patients having hereditary angioedema with plasminogen gene mutation K330E	28
Gender and geographically based disparities among editors and editorial board members in highly cited allergy journals	28
Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital	27
Effectiveness of Carboplatin-Prescreening Intradermal Skin Tests to Reduce Unanticipated Immediate Hypersensitivity Reactions: A Comparative Study	27
Clinical Assessment of Chronic Rhinosinusitis	27
Teleallergy: Where Have We Been and Where Are We Going?	27
Risk Factors and Age-Related Patterns of Asthma-Like Symptoms in Early Childhood	27
Management of Mastocytosis and Mast Cell Activation in Children	26
Outcomes among racial and ethnic minority groups with X-linked agammaglobulinemia from the USIDNET registry	26
Acculturation and asthma in Asian American adults	26

The Prevalence of IgE-Mediated Food Allergy and Other Allergic Diseases in the First 10 Years: The Population-Based, Longitudinal HealthNuts Study	26
Correction	26
Patient Perceptions of Penicillin Allergy Testing in a Public Health System	26
Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort	26
Erratum	26
The Use of Flexible Rhinolaryngoscopy for Allergy-Immunology Practice	26
Key Symptoms in Bronchial Asthma Diagnosis: Identification via Decision Tree Modeling	26
The Role of Maternal Diet and Supplements During Pregnancy and Lactation in the Prevention and Development of Food Allergies and Atopic Dermatitis	25
Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts	25
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma	25
Social Determinants and Quality of Life in Food Allergy Management and Treatment	25
Patient Global Impression of Severity Scale in Chronic Cough: Validation and Formulation of Symptom Severity Categories	25
Oscillometry may be used to detect bronchodilator reversibility in asthma patients with preserved spirometry	25
Outpatient epinephrine administration reduces ICU admission rates in anaphylactic reactions: A propensity score–matched cohort	24
Should We Pretreat Before We Go Nuts? Antihistamines Modestly Reduce the Side Effects of Peanut Oral Immunotherapy	24
About the Cover: A New “Image” for In Practice	24
Perceived high risk of COVID-19 vaccination: The revealing power of placebo	24
Environmental Injustice Is Associated With Poorer Asthma Outcomes in School-Age Children With Asthma in Metropolitan Atlanta, Georgia	24
Early-Life Allergen Exposure and Its Influence on Risk of Atopic Disease	24
Novel Connections of Common Childhood Illnesses Based on More Than 5 Million Diary Registrations From Birth Until Age 3 Years	24
Smoke and the Lungs	24
Folliculocentric Mycosis Fungoides Masquerading as Angioedema and Allergic Contact Dermatitis	24
Microbial Therapeutics for the Prevention and Treatment of Food Allergy	24
Contact Dermatitis of a Surgical Wound	24
Exercising with Asthma: A Slow Burn or a Quick HIIT?	24
A Community-Based Participatory Research Approach to Understanding Childhood Asthma in the Navajo Nation	24
Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective	24
Pulmonary Infiltrates With Hypereosinophilia	24
Novel Diagnostic Approaches for Eosinophilic Lung Diseases	24
Cover 1	24
Original Article Highlights From This Issue	23
Patient-Centered Immunotherapy: Empowering Patients With Dosing Schedule Education and Self-Tracking Modality	23
Risk of Self-Harm and the Use of Leukotriene Receptor Antagonists and Inhaled Corticosteroids: A Population-Based Study	23
Challenges and Opportunities in Asthma Prevention and Treatment	23
Exfoliative Dermatitis During Antituberculosis Treatment	23
Current Management of Allergic Rhinitis	23
Milk or egg allergy diagnosis increases the risk of eosinophilic esophagitis diagnosis	23
Biologics and Personalized Medicine in Severe Asthma: One Step at a Time	23
Subcutaneous Emphysema Presenting as Bilateral Periorbital Angioedema	23
Recent Advances in the Treatment of Eosinophilic Esophagitis	23
Information for Readers	23
Information for Readers	23
Corrections	23
Diagnosis and Treatment Options for T2-Low Asthma	23
COVID-19 and Pregnancy: Interrelationships With Asthma and Allergy	23
Elimination Diet or Swallowed Topical Steroid Treatment of Pediatric Eosinophilic Esophagitis: Five-Year Outcomes	23
Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab	22
Fatigue in Severe Uncontrolled Asthma	22
Allergic Mucin in Allergic Fungal Rhinosinusitis	22
Real-world effectiveness analysis of preschool cashew and walnut oral immunotherapy	22
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease	22
Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis	22
Effectiveness of sirolimus in severe refractory chronic spontaneous urticaria	22
Polycystic ovary syndrome and the risk of asthma in reproductive-age women: Insights from 2 real-world large cohorts	22
Oral immunotherapy in US allergy practice	22
The Art of Immunotherapy	22
Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma	22
Real-World Effectiveness of Biologic Therapy in Allergic Bronchopulmonary Aspergillosis	22
Comparison of Standard, Cluster, and Rush Allergy Immunotherapy Buildup Protocols	22
Altered Symptom Perception in Children With Asthma Is Associated With Poor Childhood Opportunity and Adverse Outcomes	22
Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review	22
More Than Moderate-Dose Inhaled Corticosteroid Therapy for Difficult-to-Treat Asthma: One Step Too Many?	22
Analyzing Racial Disparities in Pediatric Atopic Comorbidity Emergency Department Visitation Using Electronic Health Records	22
Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy	22
Beyond Avoidance: Advanced Therapies for Contact Dermatitis	22
Housing Mobility Intervention and the Impact on Pediatric Asthma Morbidity: A Novel Asthma-Directed Therapy	22
Novel Questionnaires for Assessing Signs and Symptoms of Eosinophilic Esophagitis in Children	22
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical presentation and outcomes in people of color	21
Cover 1	21
Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights	21
Delayed Skin Testing for Systemic Medications: Helpful or Not?	21
Cautious interpretation of dupilumab’s superiority in asthma: Methodological limitations and subgroup-specific efficacy	21
Association between social needs and asthma control among children evaluated at a single-center high-risk asthma clinic	21
Efficacy and Safety of Oral Antihistamines for Allergic Rhinitis: Network Meta-Analysis	21
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma	20
A novel splice-site mutation in NFKB1 presenting as common variable immunodeficiency and postoperative hyperinflammation responsive to anti–IL-1 therapy	20
Inhaled Corticosteroid–Induced Adrenal Suppression in Patients With Asthma Detected by Metabolomic Profiling	20
Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations	20
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions	20
Pretreatment with ibrutinib facilitates rapid drug desensitization in a difficult case of brentuximab vedotin–induced anaphylaxis	20
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus	20
Association of Asthma and Rheumatoid Arthritis: Conundrum Still Unsolved	20
Impact of Antihyperglycemic Drugs on Asthma Outcomes: Diversifying the Research Portfolio	20
Case report: Recall dermatitis at patch-test sites after oral provocation with mesalazine	20
Asthma Lowers the Risk of COVID Hospitalization in Children: Impact of Symptom Control Status	20
Cover 1	20
Association Between Blood Eosinophils and Neutrophils With Clinical Features in Adult-Onset Asthma	20
Cover 1	20
Reply to “Challenging dated conceptions to advocate for evidence-informed care in multiple chemical sensitivity”	20
Cover 1	20
Phenytoin-Induced Toxic Epidermal Necrolysis in a Pediatric Patient	20
Inborn Errors of Immunity: A Role for Functional Testing and Flow Cytometry in Aiding Clinical Diagnosis	20
Clinical Remission in Patients With Biologic-Naïve Asthma: A Multicenter Study in Japan	20
Demographic and clinical variations in pediatric eosinophilic esophagitis: Insights from a multidisciplinary clinic	20
Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review	20